These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


216 related items for PubMed ID: 7733184

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Cytomegalovirus retinitis and viral resistance. Prevalence of resistance at diagnosis, 1994. Cytomegalovirus Retinitis and Viral Resistance Study Group.
    Jabs DA, Dunn JP, Enger C, Forman M, Bressler N, Charache P.
    Arch Ophthalmol; 1996 Jul; 114(7):809-14. PubMed ID: 8660163
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Cytomegalovirus resistance to ganciclovir and clinical outcomes of patients with cytomegalovirus retinitis.
    Jabs DA, Martin BK, Forman MS, Hubbard L, Dunn JP, Kempen JH, Davis JL, Weinberg DV, Cytomegalovirus Retinitis and Viral Resistance Study Group.
    Am J Ophthalmol; 2003 Jan; 135(1):26-34. PubMed ID: 12504693
    [Abstract] [Full Text] [Related]

  • 5. Cytomegalovirus retinitis and viral resistance: 3. Culture results. CMV Retinitis and Viral Resistance Study Group.
    Jabs DA, Enger C, Dunn JP, Forman M, Hubbard L.
    Am J Ophthalmol; 1998 Oct; 126(4):543-9. PubMed ID: 9780099
    [Abstract] [Full Text] [Related]

  • 6. Combination ganciclovir and foscarnet in the treatment of clinically resistant cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome.
    Kuppermann BD, Flores-Aguilar M, Quiceno JI, Rickman LS, Freeman WR.
    Arch Ophthalmol; 1993 Oct; 111(10):1359-66. PubMed ID: 8216016
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Pathophysiology and treatment of clinically resistant cytomegalovirus retinitis.
    Flores-Aguilar M, Kuppermann BD, Quiceno JI, Dankner WM, Wolf DG, Capparelli EV, Connor JD, Sherwood CH, Fullerton S, Gambertoglio JG.
    Ophthalmology; 1993 Jul; 100(7):1022-31. PubMed ID: 8391674
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Mutation in region III of the DNA polymerase gene conferring foscarnet resistance in cytomegalovirus isolates from 3 subjects receiving prolonged antiviral therapy.
    Chou S, Marousek G, Parenti DM, Gordon SM, LaVoy AG, Ross JG, Miner RC, Drew WL.
    J Infect Dis; 1998 Aug; 178(2):526-30. PubMed ID: 9697736
    [Abstract] [Full Text] [Related]

  • 11. Cytomegalovirus (CMV) culture results, drug resistance, and clinical outcome in patients with AIDS and CMV retinitis treated with foscarnet or ganciclovir. Studies of Ocular Complications of AIDS (SOCA) in collaboration with the AIDS Clinical Trial Group.
    J Infect Dis; 1997 Jul; 176(1):50-8. PubMed ID: 9207349
    [Abstract] [Full Text] [Related]

  • 12. Therapeutic options for resistant cytomegalovirus retinitis.
    Kuppermann BD.
    J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Jul; 14 Suppl 1():S13-21. PubMed ID: 9058613
    [Abstract] [Full Text] [Related]

  • 13. Evaluation of cytomegalovirus retinitis management. Outcome of four years of cytomegalovirus therapy.
    Ries E, Mühlbauer B, Ruhswurm I, Krepler K, Derbolav A, Svolba G, Rieger A, Wedrich A.
    Ophthalmologica; 1998 Jul; 212(4):239-43. PubMed ID: 9672212
    [Abstract] [Full Text] [Related]

  • 14. Phase II dose-ranging trial of foscarnet salvage therapy for cytomegalovirus retinitis in AIDS patients intolerant of or resistant to ganciclovir (ACTG protocol 093). AIDS Clinical Trials Group of the National Institute of Allergy and Infectious Diseases.
    Jacobson MA, Wulfsohn M, Feinberg JE, Davis R, Power M, Owens S, Causey D, Heath-Chiozzi ME, Murphy RL, Cheung TW.
    AIDS; 1994 Apr; 8(4):451-9. PubMed ID: 8011248
    [Abstract] [Full Text] [Related]

  • 15. Emergence and prevalence of cytomegalovirus UL97 mutations associated with ganciclovir resistance in AIDS patients.
    Gilbert C, Handfield J, Toma E, Lalonde R, Bergeron MG, Boivin G.
    AIDS; 1998 Jan 22; 12(2):125-9. PubMed ID: 9468360
    [Abstract] [Full Text] [Related]

  • 16. Therapy with a combination of intravitreal foscarnet and intravenous ganciclovir in clinically resistant cytomegalovirus retinitis and patients with acquired immunodeficiency syndrome.
    Guembel HO, Hofmann F, van Even G, Cinatl J, Makabe R.
    Ger J Ophthalmol; 1996 Nov 22; 5(6):490-1. PubMed ID: 9479542
    [No Abstract] [Full Text] [Related]

  • 17. [Foscarnet for cytomegalovirus retinitis in a patient with acquired immunodeficiency syndrome].
    Nagata Y, Fujino Y, Ono A, Mochizuki M, Mouri H, Oka S, Kimura S, Shimada K.
    Nippon Ganka Gakkai Zasshi; 1994 Jul 22; 98(7):710-5. PubMed ID: 8067306
    [Abstract] [Full Text] [Related]

  • 18. Mutations conferring foscarnet resistance in a cohort of patients with acquired immunodeficiency syndrome and cytomegalovirus retinitis.
    Weinberg A, Jabs DA, Chou S, Martin BK, Lurain NS, Forman MS, Crumpacker C, Cytomegalovirus Retinitis and Viral Resistance Study Group, Adult AIDS Clinical Trials Group Cytomegalovirus Laboratories.
    J Infect Dis; 2003 Mar 01; 187(5):777-84. PubMed ID: 12599051
    [Abstract] [Full Text] [Related]

  • 19. Mutations conferring ganciclovir resistance in a cohort of patients with acquired immunodeficiency syndrome and cytomegalovirus retinitis.
    Jabs DA, Martin BK, Forman MS, Dunn JP, Davis JL, Weinberg DV, Biron KK, Baldanti F, Cytomegalovirus Retinitis and Viral Resistance Study Group.
    J Infect Dis; 2001 Jan 15; 183(2):333-337. PubMed ID: 11120934
    [Abstract] [Full Text] [Related]

  • 20. Detection of ganciclovir resistance in patients with AIDS and cytomegalovirus retinitis: correlation of genotypic methods with viral phenotype and clinical outcome.
    Jabs DA, Martin BK, Ricks MO, Forman MS, Cytomegalovirus Retinitis and Viral Resistance Study Group.
    J Infect Dis; 2006 Jun 15; 193(12):1728-37. PubMed ID: 16703517
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.